The Collaborative Fund of the CGA was created in 2012 to provide a funding mechanism for projects that support the mission of the CGA-ICC.
Below is a description of the FUND including details on eligibility, submission instructions and deadline information. To download the PDF version of the "Call for Proposals", click here.
The Collaborative Fund of the CGA is supported by the members of the CGA and through the generous, unrestricted matching grants of our industry sponsors:
COLLABORATIVE FUND OF THE CGA - CALL FOR PROPOSALS
The Collaborative Fund seeks to directly promote the mission of the CGA through the financial support of activities that disseminate knowledge and promote scientific discovery that will improve the lives of patients and families with inherited colorectal cancer. As part of the CGA's commitment to its mission and its membership, the Collaborative Fund Committee invites members in good standing to submit proposals that address any component of the CGA's mission:
1. To improve quality of care for patients and their families with inherited colorectal cancer.
2. To educate physicians and other healthcare professionals on the etiology, natural history, molecular genetics and clinical management of the inherited colorectal cancer syndromes.
3. To be a resource for institutions and individuals interested in beginning or maintaining a registry for families with inherited colorectal and gastrointestinal cancer syndromes.
4. To provide a forum for the presentation of data, the discussion of controversial areas involved in the care of patients and families with inherited colorectal cancer syndromes, and to facilitate collaborative studies.
5. To address issues concerning patients and families with inherited colorectal cancer that is of particular interest to citizens and healthcare providers of the Americas.
Awards of up to $20,000 will be given to unique and creative projects based on competitive review. Preliminary or pilot projects do not require previous work or preliminary data. These awards are not designed to fund ongoing activities or laboratory based studies. Grants submitted with matching funds will receive special attention. The number of awards granted per year by the Collaborative Fund Committee will be determined in advance based on funds available. Each award will be for one year; however, competitive renewal for a second year is possible based on documentation of productivity.
The proposed research or activity must be investigator-initiated and conducted within North, Central, or South America
All active members of the CGA-ICC, regardless of the degree or title, are encouraged to submit
Members of the CGA-ICC Executive Council or Collaborative Fund Committee are ineligible for this award
Investigators may submit one application per funding cycle
The awarding of a grant, or renewal of an existing grant, is at the discretion of the Collaborative Fund Committee and can be suspended from year to year A submitted proposal cannot be under consideration for funding by another agency, either local or national, at the time of submission other than in the form of a matching grant. When tied to a matching grant, funding of the Collaborative Fund award is contingent on successful funding of the matching grant.
The submitting investigator/organizer agrees to complete the project based on the budget submitted.
Salary support, travel funds or institutional indirect costs are not allowed A progress report will be submitted at the end of the sixth month of funding to the Collaborative Fund Committee with a final report being submitted within three months of completion of the grant period.
Successful applicants must agree to acknowledge CGA-ICC Collaborative Fund support in any publications or presentations that result from the research or project.
All awards will be recognized at the annual meeting. One or more of the investigators participating in the project are required to present their findings or outcomes of the project to the CGA-ICC membership at the annual meeting of the organization. Travel funds are the responsibility of the individual; however to facilitate this presentation, the principle investigator or their designate will be offered complementary meeting registration for the meeting in which they present their project.
Completed applications (as defined below) must be received by 5:00 PM EST, August 1, 2016.
In evaluating the merits of an application, the Committee will consider the following:
The proposal Hypothesis/Objectives/Specific Aims and how these address the mission of the organization
Clinical significance or relevance of the project as it pertains to the field of inherited colorectal cancer syndromes
Number of individuals or institutions that will benefit from the proposal
Availability of other resources to fund the proposal
Ability of the investigator(s) to complete the Specific Aims of the proposal
Project feasibility (including availability of adequate resources, personnel, and facilities)
Instructions for Submission:
Applications are required to include the following elements:
A limit of 10 pages
Documents should be formatted using 1" margins
Font size no smaller than 11 point
FAILURE TO ADHERE TO THESE INSTRUCTIONS WILL CAUSE THE GRANT APPLICATION TO BE RETURNED WITHOUT REVIEW.
All e-mail submissions should be submitted as a PDF with signature sheets. Please submit to Steven H. Erdman, MD at email@example.com
All mail submission must include signature sheets and mailed to:
Steven H. Erdman, MD
Division of Gastroenterology, Hepatology and Nutrition
Nationwide Children's Hospital
700 Children's Drive
Columbus, OH 43205-2664
ALL sections below are counted in the 10 page limit
Background/Significance, Hypothesis, and Specific Aims B
Briefly review background material for the proposal while critically evaluating existing knowledge, and present the significance of the topic.
Clearly and concisely state the hypothesis to be tested and/or what the project is intended to accomplish.
Research Plan (maximum 3 pages)
Pitfalls and Alternative Approaches
Resources Available and Feasibility to Complete Research
List all citations of literature at the end of the research plan, in the order in which they are cited in the proposal.
Each complete citation must include the names of all authors, the complete title of any article, the name of the book or journal, volume number, page numbers, and year of publication.
Institutional Review Board (IRB) status
If the proposal involves the participation of human subjects, this section MUST include either a draft of the consent form or the IRB-approved study consent forms; or (if applicable) institutional review board approval for the use of human subjects.
Please note IRB approval is required before release of funding, but IRB approval is not required at the time of proposal submission.
Conflict of interest
All applications should consider and address conflict of interest issues regarding copyright materials (device and drug patents) as necessary.
A proposal budget should be prepared as a separate document. Indicate how the funds will be allocated and justify each budget item.
THE SECTIONS BELOW ITEMS ARE EXCLUDED FROM THE 10 PAGE LIMIT
Supporting Letters: A letter of support from the home sponsoring institution indicating their willingness to provide necessary administrative assistance as well as time and financial support to present at the CGA-ICC national meeting is required.
Provide letters of support from all collaborators particularly if multiple institutions are involved.
Biographical Sketch for Primary Investigator and Co-investigators (NIH format or similar limited to 2 pages)